Centene withdraws financial guidance, impacting sector with fears of rising costs and challenging conditions.

From StockStory: 2025-07-02 15:05:00

Elevance Health (NYSE:EVH) shares dropped 9.9% as Centene withdrew its financial guidance due to lower market growth and higher claim numbers. This news sparked sector-wide fears of rising costs and challenging conditions, impacting peers like Molina and UnitedHealth Group. Market reaction suggests investors consider this news meaningful, though not fundamentally changing the business perception. Elevance Health is down 2.8% YTD and trades 36.7% below its 52-week high. Thematic investing potential is recognized, with a focus on profitable growth stocks like an under-the-radar AI beneficiary.



Read more at StockStory: Why Elevance Health (ELV) Shares Are Sliding Today